Avectas Partners With Vycellix

Both Avectas and Vycellix are partners in NextGenNK, a center based on the advancement of NK Cell-based cancer immunotherapies in Stockholm, Sweden. The two companies will combine their know-how to progress the novel… read more

en_USEnglish
zh_CN简体中文 ja日本語 ko_KR한국어 zh_TW繁體中文 en_USEnglish
Open chat
Come chat with us!
Hello! How can I help you?
Powered by